Grow Therapy Raises $150M for AI-Driven Mental Health
- •Grow Therapy secures $150M Series D funding to expand mental health partnerships.
- •AI-powered ambient listening tools reduced provider documentation time by nearly 70%.
- •Platform serves over 2 million patients with a network of 125 insurance payers.
Grow Therapy's Series D funding round, led by TCV and Goldman Sachs Alternatives, signals a significant shift toward integrated, tech-enabled mental health solutions. By targeting primary care physicians—who currently deliver 60% of mental healthcare in the U.S.—the company is building a bridge between physical and behavioral health through a seamless referral and data-sharing platform.
The company’s technological evolution is heavily anchored in artificial intelligence. Since 2025, Grow has deployed AI-driven ambient listening and patient journaling tools designed to enhance engagement and reduce burnout. The ambient listening feature, which captures session notes in real-time, has reportedly reduced provider documentation time by 70%, allowing therapists to dedicate more bandwidth to clinical care rather than administrative overhead.
With a network spanning 125 payers and 25 Medicaid plans, Grow is also leaning into value-based care, where provider compensation is linked to patient outcomes rather than service volume. This approach, combined with high patient satisfaction scores (NPS of 85), positions the firm as a leader in the competitive landscape of employer-sponsored healthcare and specialized behavioral health management.